Companies Tela Bio, Inc.
Tela Bio (TELA): executive pay, fiscal 2025
Free brief. Every figure links to the company’s own filing.
Velarion Intel: free for 3 days, no card →Email me Tela Bio, Inc.’s executive pay brief as a PDF
You get it on this page the moment you ask, and a copy by email. Every figure is cited to its filing.
After the PDF, up to three short notes on the deeper reports for this company. Reply “unsubscribe” to any of them, any time.
CEO pay, last three years
- $2,105,341FY2024
- $1,969,555FY2025
CEO total pay was $1,969,555 in fiscal 2025, down from $2,105,341 in fiscal 2024.
FY2025: salary $639,467 · stock awards $405,280 · option awards $595,680
Frequently asked questions
Answers are drawn only from the figures disclosed in this brief and cited to their location in the source filing. Where a figure required for an answer is not disclosed, that is stated rather than estimated.
Full detail
Every table from the filing. Open any section.
Summary compensation table
| Named executive officer | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension / NQDC | All other | Total |
|---|---|---|---|---|---|---|---|---|
| Antony Koblish | $639,467 | — | $405,280 | $595,680 | $326,128 | — | $3,000 | $1,969,555 |
| Chief Executive Officer | ||||||||
| Roberto Cuca | 484,981 | — | 155,040 | 227,936 | 164,894 | — | 3,000 | 1,035,851 |
| Chief Operating Officer, Chief Financial Officer and Corporate Secretary | ||||||||
| Jeffrey Blizard | 277,083 | 150,000 | 159,867 | 235,085 | 94,208 | — | 36,472 | 952,715 |
| President | ||||||||
A dash means the company reported no figure in that column; 0 means it reported zero. Figures are as printed in the filing, without adjustment.
Three-year trend — total compensation per named executive
| Named executive officer | FY2025 total | FY2024 total | FY2023 total | Δ FY2024→2025 |
|---|---|---|---|---|
| Antony Koblish | $1,969,555 | $2,105,341 | — | ↓ −135,786 |
| Roberto Cuca | 1,035,851 | 1,081,307 | — | ↓ −45,456 |
| Jeffrey Blizard | 952,715 | — | — | — |
Prior-year totals as disclosed in the corresponding proxy; deltas are computed values with the derivation shown in the register.
Incentive-plan design — the Compensation Discussion & Analysis
The compensation of our named executive officers generally consists of base salary, annual incentive opportunities, long term incentive compensation in the form of equity awards and other benefits. Our equity-based incentive awards are designed to align the interests of our stockholders with those of our named executive officers.
| CEO STI target (% of salary) | — |
|---|---|
| CEO LTI target (% of salary) | — |
| Independent consultant | — |
| Clawback policy | true |
| Anti-hedging | true |
| Anti-pledging | true |
Equity grants and outstanding awards
No plan-based awards are on file for this fiscal year.
Outstanding equity awards at fiscal year-end 2025
| Executive | Award | Shares unvested | Exercise price | Market value unvested |
|---|---|---|---|---|
| Roberto Cuca | Option | 1,109 | 11.75 | — |
| Antony Koblish | Option | 3,313 | 11.98 | — |
| Roberto Cuca | RSU | 3,875 | — | 4,573 |
| Jeffrey Blizard | RSU | 4,250 | — | 5,015 |
| Jeffrey Blizard | Option | 4,650 | 5.71 | — |
| Jeffrey Blizard | RSU | 7,950 | — | 9,381 |
| Roberto Cuca | Option | 8,080 | 10.5 | — |
| Roberto Cuca | RSU | 8,850 | — | 10,443 |
| Antony Koblish | RSU | 11,625 | — | 13,718 |
| Jeffrey Blizard | Option | 11,700 | 1.39 | — |
| Roberto Cuca | RSU | 21,900 | — | 25,842 |
| Roberto Cuca | Option | 23,130 | 7.07 | — |
| Roberto Cuca | PSU | 24,764 | — | 29,222 |
| Antony Koblish | Option | 28,030 | 10.5 | — |
| Antony Koblish | RSU | 30,600 | — | 36,108 |
| Roberto Cuca | RSU | 57,000 | — | 67,260 |
| Antony Koblish | RSU | 58,125 | — | 68,588 |
| Antony Koblish | Option | 61,317 | 7.07 | — |
| Roberto Cuca | Option | 83,800 | 2.72 | — |
| Antony Koblish | PSU | 85,772 | — | 101,211 |
| Jeffrey Blizard | RSU | 104,800 | — | 123,664 |
| Antony Koblish | RSU | 149,000 | — | 175,820 |
| Jeffrey Blizard | Option | 154,100 | 1.42 | — |
| Antony Koblish | Option | 219,000 | 2.72 | — |
Director compensation
| Director | Cash fees | Stock awards | Option awards | Non-equity incentive | All other | Total |
|---|---|---|---|---|---|---|
| Doug EvansIndependent · Board Chair · Not standing for re-election | $99,153 | $11,051 | $16,263 | — | — | $126,467 |
| Lisa ColleranIndependent · Departed during FY | 65,000 | 11,051 | 16,263 | — | — | 92,314 |
| Federica O'Brien | 65,000 | 11,051 | 16,263 | — | — | 92,314 |
| Vince BurgessIndependent | 60,000 | 11,051 | 16,263 | — | — | 87,314 |
| Kurt AzarbarzinIndependent · NCGC | 57,500 | 11,051 | 16,263 | — | — | 84,814 |
| Betty Jo RocchioIndependent | 0 | 17,649 | 25,974 | — | — | 43,623 |
| William PlovanicIndependent | 0 | 14,668 | 21,587 | — | — | 36,255 |
Board fee structure and ownership guideline
| Annual cash retainer | $45,000 |
|---|---|
| Annual equity retainer | — |
| Per board meeting fee | — |
| Committee chair fees (audit / comp / nom-gov) | 20,000 / 15,000 / 10,000 |
| Stock ownership guideline | — |
Total cost of the board
| Component | FY2025 |
|---|---|
| Cash retainers and fees | $346,653 |
| Equity awards (grant-date value) | $87,572 |
| All other compensation | $0 |
| Total cost of the board | $434,225 |
Computed as the sum of the director compensation table rows above; inputs and formula shown in the register.
Peer group, and who names Tela Bio as a peer
Companies that benchmark against TELA
1 company names TELA as a compensation peer
- Apyx Medical CorpAPYXFY2025
- Sight Sciences, Inc.SGHTFY2025
Each company listed discloses TELA in its own benchmarking peer group, as disclosed in each company's most recent proxy statement within the last two proxy seasons. Two companies are therefore absent by design: one that named TELA in an earlier year and no longer does, and one whose own most recent disclosure is older than the last two seasons.
Chief executive pay against the peer group
Most recent fiscal-year chief executive compensation at each disclosed peer, taken from that company’s own proxy statement.
| Rank | Company | FY | Chief executive | Salary | Stock awards | Option awards | Non-equity incentive | Total |
|---|---|---|---|---|---|---|---|---|
| 1 | Tela Bio, Inc. | 2025 | Antony Koblish | $639,467 | $405,280 | $595,680 | $326,128 | $1,969,555 |
Each peer’s compensation is from its most recently filed proxy; fiscal years differ by company. Each peer’s figures come from its own filings; the subject company is highlighted. Peers whose chief executive compensation is outside our coverage universe are stated as such, never left blank.
Say-on-pay history and pay ratio
No say-on-pay vote is on file for this company.
Insider trades since the proxy
No insider equity transactions reported since the proxy statement.
Sources (13 citations)
Each figure is listed with the filing it comes from, where it appears in that filing, and the value as printed. Any figure can be independently confirmed against the source.
- Section 01, Antony Koblish. DEF 14A, filed 2026-04-30. Section “Executive Compensation”. As printed: 1,969,555. View filing ↗
- Section 01, Roberto Cuca. DEF 14A, filed 2026-04-30. Section “Executive Compensation”. As printed: 1,035,851. View filing ↗
- Section 01, Jeffrey Blizard. DEF 14A, filed 2026-04-30. Section “Executive Compensation”. As printed: 952,715. View filing ↗
- Section 08, Doug Evans. DEF 14A, filed 2026-04-30. Section “Director Compensation”. As printed: 126,467. View filing ↗
- Section 08, Lisa Colleran. DEF 14A, filed 2026-04-30. Section “Director Compensation”. As printed: 92,314. View filing ↗
- Section 08, Federica O'Brien. DEF 14A, filed 2026-04-30. Section “Director Compensation”. As printed: 92,314. View filing ↗
- Section 08, Vince Burgess. DEF 14A, filed 2026-04-30. Section “Director Compensation”. As printed: 87,314. View filing ↗
- Section 08, Kurt Azarbarzin. DEF 14A, filed 2026-04-30. Section “Director Compensation”. As printed: 84,814. View filing ↗
- Section 08, Betty Jo Rocchio. DEF 14A, filed 2026-04-30. Section “Director Compensation”. As printed: 43,623. View filing ↗
- Section 08, William Plovanic. DEF 14A, filed 2026-04-30. Section “Director Compensation”. As printed: 36,255. View filing ↗
- Section 01 trend, Δ column (computed). Computed. Δ = current-FY total − prior-FY total per named officer.
- Section 09b board cost (computed). Computed. Cash 346,653 + equity 87,572 + all other 0 = 434,225, summed across the director compensation table rows.
- Tela Bio, Inc. (subject), Section 10b CEO total. DEF 14A, filed 2026-04-30. CEO total compensation as printed in Tela Bio, Inc.'s own proxy. As printed: 1,969,555. View filing ↗